Hepatocellular carcinoma (HCC) generally develops as a ... The identifiable population at risk makes screening a realistic possibility, and liver imaging is recommended every 6 months for patients ...

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

Medscape Medical News, July 08, 2024 HCC Screening of At-Risk Adults Improves Detection, Survival Hepatocellular carcinoma screening was associated with earlier detection and improved survival ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Other areas of expertise include analyzing treatment outcomes data for patients with gastrointestinal cancers, as well as the identification of new treatments for fibrolamellar hepatocellular ...

Find Most Common Cancers And Prevention Latest News, Videos & Pictures on Most Common Cancers And Prevention and see latest updates, news, information from NDTV.COM. Explore more on Most Common ...